What is the treatment for ulcers?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Peptic Ulcers

The first-line treatment for peptic ulcers is proton pump inhibitor (PPI) therapy for 6-8 weeks, with H. pylori eradication therapy if infection is present, and discontinuation of NSAIDs if applicable. 1, 2

Pharmacological Management

First-Line Treatment

  • Start PPI therapy (such as omeprazole 20-40mg once daily) as soon as possible after diagnosis for 6-8 weeks to allow complete mucosal healing 1
  • For active duodenal ulcers, omeprazole 20mg daily heals 75% of ulcers within 4 weeks, compared to only 27% with placebo 3
  • For active gastric ulcers, short-term treatment (4-8 weeks) with PPIs is indicated 3

H. pylori Eradication

  • Test all patients with peptic ulcers for H. pylori infection 1
  • For H. pylori-positive ulcers, eradication therapy is strongly recommended to prevent recurrent bleeding and promote healing 4
  • Standard triple therapy for 14 days is recommended if low clarithromycin resistance is present:
    • PPI + clarithromycin + amoxicillin or metronidazole 4
    • Omeprazole 20mg twice daily + clarithromycin 500mg twice daily + amoxicillin 1g twice daily for 10 days shows 77-90% H. pylori eradication rates 3
  • Sequential therapy for 10 days is recommended if high clarithromycin resistance is detected 4
  • H. pylori eradication decreases peptic ulcer recurrence rates from approximately 50-60% to 0-2% 2

NSAID-Associated Ulcers

  • Discontinue NSAID therapy when possible, as this heals 95% of ulcers and reduces recurrence from 40% to 9% 2
  • Maintain PPI therapy long-term if NSAID therapy must continue 1
  • Omeprazole 20mg daily is more effective than ranitidine or misoprostol for healing NSAID-associated ulcers, with 83% healing rates for gastric ulcers and 93% for duodenal ulcers at 8 weeks 5

Management of Bleeding Ulcers

Resuscitation

  • Maintain hemoglobin levels >7 g/dl during resuscitation 6
  • Follow resuscitation targets similar to those used in bleeding trauma patients 6

Endoscopic Management

  • Endoscopy is recommended as first-line treatment for diagnosis and management of bleeding ulcers 1
  • Pre-endoscopy erythromycin improves visualization and reduces the need for repeat endoscopy 1, 6
  • For bleeding ulcers, high-dose PPI therapy is recommended: 80mg bolus followed by 8mg/hour continuous infusion for 72 hours 1, 6
  • Dual modality endoscopic hemostasis is suggested for actively bleeding ulcers 6
  • Doppler probe-guided endoscopic hemostasis can reduce 30-day rebleeding rates 6

Risk Stratification

  • Stratify patients based on the Blatchford score 6:
    • Very low-risk: outpatient endoscopy 6
    • Low-risk: early inpatient endoscopy (≤24h of admission) 6
    • High-risk: urgent inpatient endoscopy (≤12h of admission) 6

Duration of Treatment

  • PPIs are recommended for 6-8 weeks following endoscopic treatment of bleeding ulcers 6, 1
  • Long-term PPI is not recommended unless the patient has ongoing NSAID use 6
  • For H. pylori-positive ulcers, standard triple therapy should be started after 72-96 hours of intravenous PPI administration 4

Common Pitfalls and Caveats

  • Failure to test for H. pylori can lead to recurrence rates of 40-50% over 10 years 1
  • PPIs may reduce absorption of medications requiring an acidic environment 1
  • Proton pump inhibitors should not replace urgent endoscopy in patients with active bleeding 1, 6
  • H. pylori-negative ulcers are more aggressive, with higher recurrence rates and increased risk of bleeding and perforation, and may require long-term PPI therapy 7

Special Considerations

  • For patients with refractory bleeding despite combined pharmacological and endoscopic therapy, surgical intervention may be necessary 8
  • Angioembolization may be considered in hemodynamically stable patients where endoscopic hemostasis fails twice or is not possible 8

References

Guideline

Management of Stomach Ulcers

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Antibiotic Use in Nonhealing Ulcers

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Use of proton-pump inhibitors in complicated ulcer disease and upper gastrointestinal tract bleeding.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1999

Guideline

Management of Recurrent Hematemesis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.